This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

4 Feb 2014

New FDA Guidance for Drug Development Tools

FDA has published a new Guidance for Industry and FDA Staff: "Qualification Process for Drug Development Tools".


This guidance describes the process for qualifying drug development tools (DDT), such as, biomarkers, clinical outcome assessments (COAs), and animal models for drug development.


For more information, click here.

Related News